Parexel on the pulse

January 19, 2021

Parexel regulatory expert, Mark Birse, gives an update on BREXIT.

Previous Video
CAR-T: A patient’s cell therapy success story
CAR-T: A patient’s cell therapy success story

Clinical trials of (CAR) T-cell therapies can present unprecedented enrolment challenges. How can we encour...

Next Video
Impact of Real-World Evidence on Payers & Patients
Impact of Real-World Evidence on Payers & Patients

Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration speaks with Parexel’s Peyton Ho...